Product Catalogue 2017 Clinical and Industrial Microbiology
|
|
- Samson Bryant
- 6 years ago
- Views:
Transcription
1 Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs 9179 Amoxicillin AML x0 Discs 900 Amoxicillin + Clavulanic acid AUG 3 (2+1) x0 Discs 9191 Amoxicillin + Clavulanic acid AUG 7. x0 Discs 92 Amoxicillin + Clavulanic acid AUG (20+) x0 Discs 9048 Ampicillin AMP 2 x0 Discs 911 Ampicillin AMP x0 Discs 9006 Ampicillin + Sulbactam AMS 20 (+) x0 Discs 9031 Ampliclox (AMP + CX) ACL (2+) x0 Discs 9122 Azithromycin AZM 1 x0 Discs 9 Azlocillin AZL 7 x0 Discs 9007 Aztreonam ATM x0 Discs 9008 Bacitracin BA IU x0 Discs 901 Carbenicillin CAR 0 x0 Discs 9009 Cefaclor CEC x0 Discs 90 Cefadroxil CDX x0 Discs 902 Cefamandole MA x0 Discs 9014 Cefazolin KZ x0 Discs 901 Cefepime FEP x0 Discs 9219 Cefepime FEP x0 Discs 9220 Cefepime FEP x0 Discs 94 Cefepime + Clavulanic acid FEL 40 (+) 6 x0 Discs 9143 Cefixime CFM x0 Discs 9089 Cefoperazone CFP x0 Discs 92 Cefoperazone CFP x0 Discs 9016 Cefoperazone CFP 7 x0 Discs 98 Cefotaxime CTX x0 Discs 912 Cefotaxime CTX 6 x0 Discs 9017 Cefotaxime + Clavulanic acid CTL 40 (+) 6 x0 Discs 9182 Cefotaxime + Clavulanic acid + Cloxacillin CTLC 6 x0 Discs 9203 Cefotetan CTT x0 Discs 9081 Cefoxitin FOX x0 Discs 9018 Cefoxitin + Cloxacillin FOC 2 (+200) x0 Discs 9144 Cefpirome CR x0 Discs 918 Cefpodoxime PX x0 Discs 9064 Cefpodoxime + Clavulanic acid PXL 11 (+1) 6 x0 Discs 9190 Cefprozil CPR x0 Discs 9112 Cefsulodin CSD x0 Discs 903 Ceftaroline CPT x0 Discs 919 Ceftaroline CPT x0 Discs 9198 Ceftazidime CAZ x0 Discs 913 Ceftazidime CAZ x0 Discs 9019 Ceftazidime + Avibactam CZA 14 x0 Discs 9206 Ceftazidime + Avibactam CZA 0 (+20) x0 Discs 920 Ceftazidime + Clavulanic acid CAL 40 (+) 6 x0 Discs 914 Ceftazidime + Clavulanic acid + Cloxacillin CALC 6 x0 Discs 9204 Ceftibuten CTB x0 Discs 91 Ceftiofur FUR x0 Discs 921 Ceftizoxime CZX x0 Discs 904 Ceftobiprole BPR x0 Discs 9242 Ceftolozane-tazobactam C/T 40 (+) x0 Discs 9246 Ceftriaxone CRO x0 Discs 923 Ceftriaxone CRO x0 Discs 9020 Cefuroxime CXM 1 x0 Discs 9232 Cefuroxime CXM x0 Discs
2 Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Cefuroxime CXM x0 Discs 9021 Cephalexin CL x0 Discs 9011 Cephalothin KF x0 Discs 9013 Cephradine CE x0 Discs 90 Chloramphenicol C x0 Discs 9128 Chloramphenicol C x0 Discs 9022 Cinoxacin CIN 0 x0 Discs 907 Ciprofloxacin CIP x0 Discs 906 Clarithromycin CLR 1 x0 Discs 9098 Clavulanic acid CLA 1 x0 Discs 9229 Clavulanic acid CLA 2 x0 Discs 9228 Clavulanic acid CLA x0 Discs 92 Clavulanic acid CLA x0 Discs 9231 Clindamycin CD 2 x0 Discs 9047 Clindamycin CD x0 Discs 9146 Cloxacillin CX x0 Discs 908 Colistin sulfate CS x0 Discs 9023 Colistin sulfate CS 2 x0 Discs 9184 Colistin sulfate CS IU x0 Discs 9141 Daptomycin (Includes Ca 2+ ) DAP x0 Discs 9090 Dicloxacillin DCX 1 x0 Discs 9093 Dipicolinic acid DP x0 Discs 9194 Doripenem DOR x0 Discs 914 Doxycycline DXT x0 Discs 909 EDTA ED x0 Discs 9087 Enrofloxacin ENR 7 x0 Discs 9233 Eravacycline ERV 20 x0 Discs 9238 Ertapenem ETP x0 Discs 9061 Ertapenem + Cloxacillin ET+CL x0 Discs 9199 Ertapenem + Phenylboronic acid ET+BO x0 Discs 9202 Erythromycin E 2 x0 Discs 9180 Erythromycin E 1 x0 Discs 9024 Florfenicol FFC 7 x0 Discs 9234 Fosfomycin FOS 0 x0 Discs 902 Fosfomycin (includes G6P) FOS 0 x0 Discs 9121 Fosfomycin (includes G6P) FOS 200 x0 Discs 99 Fosfomycin (includes 0 μg G6P) FGP 0 x0 Discs 9213 Fosfomycin (includes 200 μg G6P) FGP 200 x0 Discs 9214 Fosfomycin (includes 400 μg G6P) FGP 400 x0 Discs 921 Furazolidon FR 0 x0 Discs 9099 Fusidic acid FC x0 Discs 9049 Fusidic acid FC x0 Discs 9111 Gatifloxacin GAT x0 Discs 9169 Gentamicin CN x0 Discs 9026 Gentamicin CN x0 Discs 912 Gentamicin CN 120 x0 Discs 9124 Glucose-6-Phosphate G6P 0 x0 Discs 9216 Glucose-6-Phosphate G6P 200 x0 Discs 9217 Glucose-6-Phosphate G6P 400 x0 Discs 9218 Imipenem IMI x0 Discs 9079 Imipenem + Phenylboronic acid IMI+BO x0 Discs 908 Imipenem + Cloxacillin IMI+CL x0 Discs 9086 Imipenem + EDTA IMI+ED 760 (+70) x0 Discs 9183 Kanamycin K x0 Discs 9027 Lefamulin LMU x0 Discs 9249 Lefamulin LMU 20 x0 Discs 920 x0 Discs 92 Lincomycin MY 2 x0 Discs 9028 Lincomycin MY 1 x0 Discs 9116 Linezolid LNZ x0 Discs 91 22
3 Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Linezolid LNZ x0 Discs 9136 Lomefloxacin LOM x0 Discs 9113 Loracarbef LOR x0 Discs 9173 Mecillinam MEC x0 Discs 916 Meropenem MRP x0 Discs 9068 Meropenem + Phenylboronic acid MR+BO 6 x0 Discs 9176 Meropenem + Cloxacillin MR+CL 6 x0 Discs 917 Meropenem + Dipicolinic acid MR+DP 6 x0 Discs 9177 Meropenem + EDTA MR+ED 6 x0 Discs 9178 Methicillin MET x0 Discs 9029 Metronidazole MTZ x0 Discs 9076 Metronidazole MTZ x0 Discs 9188 Metronidazole MTZ 0 x0 Discs 9119 Mezlocillin MEZ 7 x0 Discs 9062 Minocycline MN x0 Discs 90 Miokamicin MK 1 x0 Discs 96 Moxifloxacin MOX x0 Discs 93 Mupirocin MUP x0 Discs 9189 Mupirocin MUP 200 x0 Discs 917 Nafcillin NAF 1 x0 Discs 9174 Nalidixic acid NA x0 Discs 9001 Neomycin N 7 x0 Discs 9032 Netilmicin NET x0 Discs 9170 Netilmicin NET x0 Discs 9033 Nitrofurantoin F 0 x0 Discs 9181 Nitrofurantoin F 0 x0 Discs 918 Nitrofurantoin F 0 x0 Discs 9034 Nitroxoline NI x0 Discs 9209 Norfloxacin NOR x0 Discs 903 Novobiocin NO x0 Discs 9117 Novobiocin NO x0 Discs 9063 Ofloxacin OFX x0 Discs 9080 Oritavancin ORI x0 Discs 9201 Oxacillin OX 1 x0 Discs 9036 Oxacillin OX x0 Discs 913 Oxolinic acid OA 2 x0 Discs 9002 Oxytetracycline OT x0 Discs 906 Pefloxacin PEF x0 Discs 9091 Penicillin G P 1 IU x0 Discs 91 Penicillin G P 2 IU x0 Discs 9127 Penicillin G P IU x0 Discs 9037 Penicillin G 1IU+ 1 µg Clav. acid PC 1 x0 Discs 9226 Penicillin G 1IU+ 2 µg Clav. acid PC 2 x0 Discs 9227 Penicillin G 1IU+ 3 µg Clav. acid PC 3 x0 Discs 9239 Penicillin G 1IU+ µg Clav. acid PC x0 Discs 9240 Penicillin G 1IU+ µg Clav. acid PC x0 Discs 9241 Penicillin G 1IU+ 20 µg Clav. acid PC 20 x0 Discs 924 Phenoxymethylpenicillin PV x0 Discs 9171 Phenylboronic acid BO x0 Discs 9193 Pipemidic acid PI 20 x0 Discs 9003 Piperacillin PRL x0 Discs 919 Piperacillin PRL 0 x0 Discs 9038 Piperacillin + Tazobactam TZP 36 (+6) x0 Discs 9160 Piperacillin + Tazobactam TZP 1 (0+) x0 Discs 90 Polymyxin B PB 0 IU x0 Discs 9066 Polymyxin B PB 0 IU x0 Discs 9120 Quinupristin-Dalfopristin QDA 1 x0 Discs 9161 Rifampicin RD x0 Discs 9118 Rifampicin RD x0 Discs 9039 Rokitamycin ROK x0 Discs
4 Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Roxithromycin RXT 1 x0 Discs 9060 Sisomycin SIS x0 Discs 9046 Sodium Fusidate FC x0 Discs 9131 Solithromycin SOL 1 x0 Discs 9247 Spectinomycin SPC 0 x0 Discs 9067 Spiramycin SP 0 x0 Discs 9088 Streptomycin S x0 Discs 9040 Streptomycin S 0 x0 Discs 9162 Sulbactam SU 6 x0 Discs 9212 Sulbactam SU x0 Discs 9211 Sulbactam SU 20 x0 Discs 9129 Sulfadiazine SUZ 0 x0 Discs 910 Sulfafurazole SF 0 x0 Discs 9041 Sulfamethoxazole SMX 0 x0 Discs 9084 Sulfamethoxazole SMX 0 x0 Discs 9187 Sulfaprim SXT 0 x0 Discs 9132 Sulfonamide S3 0 x0 Discs 9126 Tedizolid TZD 2 x0 Discs 9243 Tedizolid TZD x0 Discs 9244 Tedizolid TZD 20 x0 Discs 924 Teicoplanin TEC x0 Discs 900 Telithromycin TEL 1 x0 Discs 9172 Temocillin TMO 6 x0 Discs 9186 Tetracycline TE x0 Discs 9043 Tiamulin T 7 x0 Discs 9094 Ticarcillin TC 7 x0 Discs 9070 Ticarcillin + Clavulanic acid TTC 8 (7+) x0 Discs 9096 Tigecycline TGC 1 x0 Discs 9147 Tobramycin TOB x0 Discs 9044 Tobramycin TOB x0 Discs 9163 Trimethoprim TM 2. x0 Discs 9083 Trimethoprim TM x0 Discs 91 Trimethoprim-Sulfamethoxazole SXT 2 ( ) x0 Discs 9042 Tylosin TY x0 Discs 9082 Vancomycin VA x0 Discs 9164 Vancomycin VA x0 Discs 904 * Single cartridges of 0 discs are available: add /1 to the catalogue ref. no. to indicate the relevant item. Example: ref. 904/1 indicates Vancomycin µg in one single cartridge of 0 discs. 1. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M0-S27. Wayne, PA: Clinical and Laboratory Standards Institute; CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Tenth Edition. CLSI document M02-A12. Wayne, PA: Clinical and Laboratory Standards Institute; The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control as recommended by EUCAST, Version 7.1, BSAC Methods for Antimicrobial Susceptibility Testing, Version 12, May EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0, CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard - Third Edition. CLSI document M31-A3. Wayne, PA: Clinical and Laboratory Standards Institute;
5 Antimycotic discs in cartridge Description µg CLSI 8,9 Packaging* Ref. Amphotericin B AMB 20 x0 Discs 9071 Caspofungin CAS x0 Discs 916 Clotrimazole CLO 0 x0 Discs 9097 Econazole ECN x0 Discs 9072 Fluconazole FLU 2 x0 Discs 9166 Fluconazole FLU 0 x0 Discs 9069 Flucytosine AFY 1 x0 Discs 9073 Griseofulvin AGF x0 Discs 9074 Itraconazole ITC 0 x0 Discs 97 Ketoconazole KCA x0 Discs 907 Miconazole MCL x0 Discs 9077 Nystatin NY 0 IU x0 Discs 9078 Posaconazole POS x0 Discs 9167 Voriconazole VO 1 x0 Discs 9168 * Single cartridges of 0 discs are available: add /1 to the catalogue ref. no. to indicate the relevant item. Example: ref. 907/1 indicates Ketoconazole μg in one single cartridge of 0 discs. NOTE: 8. CLSI M44-A2 - Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline Second Edition (August 2009). 9. CLSI M44 S3 - Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts;Third Informational Supplement. 2
6 ESBL discs kit (according to EUCAST) Cefotaxime CTX Cefotaxime + Clavulanic acid CTL 40 (+) Ceftazidime CAZ Ceftazidime + Clavulanic acid CAL 40 (+) Cefepime FEP Cefepime + Clavulanic acid FEL 40 (+) 0 Test ESBL discs kit (according to CLSI) Cefotaxime CTX Cefotaxime + Clavulanic acid CTL 40 (+) Ceftazidime CAZ Ceftazidime + Clavulanic acid CAL 40 (+) 0 Test 9900 ESBL (chromosomal ind. AmpC) discs kit (according to EUCAST) Cefepime FEP Cefepime + Clavulanic acid FEL 40 (+) 0 Test KPC&MBL discs kit (according to EUCAST) Meropenem MRP Meropenem + Phenylboronic acid Meropenem + Cloxacillin Meropenem + EDTA MR+BO MR+CL MR+EDTA 0 Test KPC&MBL&OXA-48 discs kit Meropenem MRP Meropenem + Phenylboronic acid MR+BO Meropenem + Cloxacillin MR+CL 0 Test Meropenem + EDTA MR+EDTA Temocillin TMO 26
7 AmpC discs kit Cefotaxime Cefotaxime + Cloxacillin Ceftazidime Ceftazidime + Cloxacillin 0 Test ESBL+AmpC screen discs kit Cefotaxime Cefotaxime + Clavulanic acid 40 (+) Cefotaxime + Cloxacillin Cefotaxime + Clavulanic acid + Cloxacillin 0 Test
8 Multodisc with eight antimicrobial agents Description µg CLSI EUCAST Packaging Ref. ANAEROBES ENTEROCOCCI ENTEROBACTERIA URINE ENTEROBACTERIA 1 ENTEROBACTERIA 2 PSEUDOMONAS Carbenicillin Cefoxitin Clindamycin Chloramphenicol Erythromycin Metronidazole Ampicillin Tetracycline Tigecycline Ampicillin Linezolid Nitrofurantoin Trimethoprim-Sulfamethoxazole Vancomycin Gentamicin Teicoplanin Ampicillin Cefuroxime Ceftazidime Trimethoprim-Sulfamethoxazole Gentamicin Nitrofurantoin Norfloxacin Amikacin Aztreonam Piperacillin + Tazobactam Chloramphenicol Trimethoprim-Sulfamethoxazole Netilmicin Cefotaxime Nitrofurantoin Cefoxitin Piperacillin + Tazobactam Cefuroxime Streptomycin Netilmicin Ampicillin + Sulbactam Tobramycin Amikacin Ticarcillin Piperacillin + Tazobactam Ceftazidime Gentamicin Netilmicin Tobramycin CAR FOX CD C E MTZ AMP TE TGC AMP LNZ F SXT VA CN TEC AMP CXM CAZ SXT CN F NOR AK ATM TZP C SXT NET CTX F FOX TZP CXM S NET AMS TOB AK TC TZP CAZ CN NET TOB Multodiscs Multodiscs 92 0 Multodiscs 92 0 Multodiscs Multodiscs Multodiscs
9 Multodisc with eight antimicrobial agents Description µg CLSI EUCAST Packaging Ref. STAPH STREPTO ACINETOBACTER YEASTS Cefoxitin Netilmicin Tetracycline Erythromycin Gentamicin Rifampicin Linezolid Penicillin G Teicoplanin Vancomycin Erythromycin Tetracycline Linezolid Rifampicin Doripenem Meropenem Gentamicin Trimethoprim-Sulfamethoxazole Tobramycin Ciprofloxacin Netilmicin Caspofungin Fluconazole Posaconazole Voriconazole Amphotericin B Ketoconazole Flucytosine Nystatin FOX NET TE ERY CN RD LNZ P TEC VA E TE LNZ RD DOR MRP CN SXT TOB CIP NET CAS FLU POS VO AMB KCA AFY NY 1 IU IU 0 Multodiscs Multodiscs Multodiscs Multodiscs
10 Liofilchem Liofilchem s.r.l. Disc Dispenser Description Ref. Disc Dispenser for 1 cartridge Disc Dispenser for 6 cartridges Disc Dispenser for 8 cartridges Disc Dispenser for 12 cartridges Disc Dispenser for 16 cartridges Densitometer Description Ref. DEN-1B McFarland densitometer with built-in adapter for 18 mm tubes A-16 Adapter for 16 mm tubes CKG18, calibration kit for DEN-1, for 18mm glass tubes CKG16, calibration kit for DEN-1, for 16mm glass tubes
Product Catalogue 2016 Clinical and Industrial Microbiology
Antibiotic discs in cartridge Description μg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs
More informationAMR Industry Alliance Antibiotic Discharge Targets
AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More information2 New products for 2014
2 New products for 2014 Group B Streptococci Testing Thermo Scientific Brilliance GBS Agar Thermo Scientific TM Brilliance GBS Agar is a clear, selective chromogenic medium for the presumptive identification
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationCompliance of manufacturers of AST materials and devices with EUCAST guidelines
Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The
More informationMASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products
IVD solutions through partnership MASTDISCS AST Leading the field with a complete solution for AST and Identification disc testing Comprehensive range Premium quality products Compatible with EUCAST and
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationSMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...
SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationBrief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents
Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische
More informationI am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.
Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #116 (NQF 0058): Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationEAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia
EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia Background The Expert Advisory Group on Antimicrobial Resistance of the NH&MRC provides advice to Australian governments and
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationBritish Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate
More informationThis document is protected by international copyright laws.
Table 2C Table 2C. and s for Product Name: Infobase 2010 - Release Date: February 2010 60 Clinical and Laboratory Standards Institute. All rights reserved. Testing Conditions Medium: diffusion: MHA Broth
More informationNon-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,
Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationBSAC standardized disc susceptibility testing method (version 8)
Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for
More informationMicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS
MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS LABORATORIES ON THE FRONT LINE From the National Action Plan for Combating Antibiotic Resistant
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationWhat is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown
What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationBSI Case Report Form
BSI Case Report Form Surveillance unit Number Case Type Case ID: Patient Name Medical record Number: _ Hospital Name: Sex: Male Female Date of Birth (DD/MM/YYYY): / / Age (Years): Age/DOB (Unknown) Date
More informationدکتر فرينبز راشذ مرنذی متخصص آسيب شنبسی تشريحی و ببلينی عضو هيئت علمی آزمبيشگبه مرجع سالمت
دکتر فرينبز راشذ مرنذی متخصص آسيب شنبسی تشريحی و ببلينی عضو هيئت علمی آزمبيشگبه مرجع سالمت Antibiotical grouping Mechanisms of action Bacteriostatic Bacteriocidal Site of action Antibiotics Antibiotics
More informationLiofilchem. ID-AST systems
Liofilchem ID-AST systems Systems for ID and AST directly from clinical specimens page 1 Integral Systems for ID and AST from isolated colonies page 4 Systems for ID from isolated colonies page 6 Systems
More informationEARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017)
EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017) Questions on this document can be directed towards: Karl Mertens Scientific
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More information- the details, where possible, of the antibiotic products these companies supply or have supplied.
Under the Freedom of Information Act 2000 please could you provide me with a list of all companies currently supplying antibiotics - or that have supplied antibiotics in the last three years - to Royal
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationMain objectives of the EURL EQAS s
EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)
More informationInterpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
More informationAntimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018
Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationMIC Test Strip. for antimicrobial susceptibility testing
for antimicrobial susceptibility testing Liofilchem Liofilchem Quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) is a quantitative assay for determining the Minimum Inhibitory
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationPenicillins - EUCAST clinical MIC breakpoints (version 1.3)
EUCAST clinical MIC breakpoints - penicillins Penicillins - EUCAST clinical MIC breakpoints 2009-04-19 (version 1.3) Penicillins Click on antibiotic name to see wild type MIC distributions. Enterobacteriaceae
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationIntroduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.
Secondary Care Data Validation: What do commissioners need to know? Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2014 Introduction Antimicrobial
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationShort Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing
Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationIncluding data call, instructions for participating laboratories, data definition, reporting procedure.
EARS-Net Belgium 2016 - Protocol: Including data call, instructions for participating laboratories, data definition, reporting procedure. (version 7, 6/7/2017) Questions on this document can be directed
More informationRevolutionary Milk Analysis
Revolutionary Milk Analysis 2 Milk quality is a major concern Farmers, producers and laboratories have to meet European and international rules. They must perform even more stricter controls to ensure
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationSurveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens
Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Dr Pat Mitchell R & I Manager Production Stewardship APL CDC Conference, Melbourne June 2017 Dr Kylie Hewson
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationREVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.
REVOLUTIONARY. Are recurrent bacterial infections a frustration in your practice? WE HAVE FOUND THE ANSWER. MMinimum inimizing BBiofilm EEradication C oncentration Concentration www.becscreen.com WHY BIOFILM
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationMeasuring Antibiotic Use in NHSN
Measuring Antibiotic Use in NHSN Jonathan R. Edwards, MStat. Research Mathematical Statistician Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases SHEA
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationHUSRES Annual Report 2007 Martti Vaara.
HUSRES Annual Report 2007 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2007 report is the HUSLAB/Whonet database 2007, which contains susceptibility data on about 182.000 bacteria
More informationThe impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker
The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial
More informationRecommendations to take it forward!
Capacity Building and Strengthening of Hospital Infection Control to detect and prevent antimicrobial resistance in India AIIMS-ICMR-CDC EQAS Recommendations to take it forward! Top regional diagnostic
More informationDetecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)
Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa
More informationCurrent EU Antibiotic Maximum Residue Limits
R-Biopharm Rhône Current EU Antibiotic Maximum Residue Limits March 2011 R-Biopharm Rhône Current EU Antibiotic Limits 2 Contents Antibiotics in Food Aminoglycosides...4 Ansamycins...4 Beta-lactams...5
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More informationby author ESCMID Online Lecture Library EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010
EUCAST The European Committee on Antimicrobial Susceptibility Testing September 2010 Gunnar Kahlmeter Chairman of EUCAST Terms and acronyms AST Antimicrobial Susceptibility Testing MIC Minimum Inhibitory
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationOPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials
Clinical Monitoring of Outpatient Parenteral Antimicrobial Therapy (OPAT) and Selected Oral Antimicrobial Agents Adult Inpatient/Ambulatory Clinical Practice Guideline Appendix A. Coordinating an OPAT
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationEUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU
EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU Gunnar Kahlmeter What is new in EUCAST? New organisms breakpoints 2016 Breakpoints for exisiting agents breakpoints
More information